PubPeer
The online Journal club
login
create account
Home
Publications
Dabigatran: how the drug company withheld important analyses
BMJ (2014) -
Comments
pubmed: 25055829 issn: 1756-1833 doi: 10.1136/bmj.g4670
Deborah Cohen
Go to article
Go to preprint
BMJ
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})